STAGE IIIA BREAST CANCER
Clinical trials for STAGE IIIA BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IIIA BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo offers hope for elderly breast cancer patients avoiding surgery
Disease control CompletedThis study tested a combination of two hormone-based drugs (fulvestrant and palbociclib) in 14 older patients with hormone-sensitive breast cancer who could not have surgery or chose not to. The goal was to control the cancer and avoid the need for surgery. The treatment aims to …
Matched conditions: STAGE IIIA BREAST CANCER
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:52 UTC
-
New combo therapy may keep breast cancer from coming back
Disease control CompletedThis study tested whether adding ovarian suppression (stopping the ovaries from making estrogen) and switching to a different hormone drug (exemestane) could better prevent breast cancer from returning in premenopausal women with hormone-sensitive breast cancer. Over 3,000 women …
Matched conditions: STAGE IIIA BREAST CANCER
Phase: PHASE3 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New hope for Hard-to-Treat breast cancer: drug combo shows promise
Disease control CompletedThis study tested a drug called alisertib, either alone or combined with the hormone therapy fulvestrant, in 96 postmenopausal women with advanced breast cancer that had stopped responding to standard hormone treatments. The goal was to see if these treatments could shrink tumors…
Matched conditions: STAGE IIIA BREAST CANCER
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 18, 2026 12:00 UTC
-
Could fish oil or celecoxib tame aggressive pregnancy breast cancer?
Knowledge-focused CompletedThis study looked at whether two anti-inflammatory drugs—fish oil and celecoxib—could reduce inflammation and slow tumor growth in women with pregnancy-associated breast cancer. 42 women with breast cancer stages I to IV took one of the drugs for at least a week before their plan…
Matched conditions: STAGE IIIA BREAST CANCER
Phase: EARLY_PHASE1 • Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated May 26, 2026 07:51 UTC